Prefera OB plus DHA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alaven Pharmaceutical Llc. The primary component is Folic Acid; Heme Iron Polypeptide; Iron Dextran; Potassium Iodide; Zinc Oxide; Selenium; Cupric Sulfate; Cholecalciferol; Thiamine Mononitrate; Alpha-tocopherol Succinate, D-; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Cyanocobalamin; Biotin; Calcium Pantothenate.
| Product ID | 68220-089_c697dfae-210c-43a6-b893-f3054e74901c |
| NDC | 68220-089 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Prefera OB plus DHA |
| Generic Name | Folic Acid, Heme Iron Polypeptide, Iron Dextran, Potassium Iodide, Zinc Oxide, Selenium, Cupric Sulfate, Cholecalciferol, Thiamine Mononitrate, Alpha-tocopherol Succinate, D-, Riboflavin, Niacinamide, |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-04-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; POTASSIUM IODIDE; ZINC OXIDE; SELENIUM; CUPRIC SULFATE; CHOLECALCIFEROL; THIAMINE MONONITRATE; ALPHA-TOCOPHEROL SUCCINATE, D-; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE |
| Active Ingredient Strength | 1 mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1 |
| Pharm Classes | Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2009-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-04-01 |
| Marketing End Date | 2019-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-04 |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-04-01 |
| Marketing End Date | 2019-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-04 |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-04-01 |
| Marketing End Date | 2019-01-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-04 |
| Ingredient | Strength |
|---|---|
| FOLIC ACID | 1 mg/1 |
| SPL SET ID: | 0539ec9c-b625-4c4e-a321-e7073041c8e0 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68220-089 | Prefera OB plus DHA | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
| 68220-084 | PreferaOB | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
| 68220-083 | PreferaOB plus DHA | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |